Email ID
Password
Scrip   
Crestor's AURORA dims in dialysis patients
06 April 2009
Alex Shimmings

Starting long-term dialysis patients on rosuvastatin ( AstraZeneca's Crestor) therapy has no beneficial effect on their rate of cardiovascular deaths, heart attacks or stroke, despite lowering their LDL-cholesterol levels, the results of the AURORA study show.

The findings suggest that the...



Please Login to read the full article.
JOB OF THE WEEK Promote your vacancy here
© 2010 Informa plc. All rights reserved.
This site is owned and operated by Informa plc ("Informa") whose registered office is Mortimer House, 37-41 Mortimer Street, London, W1T 3JH. Registered in England and Wales. Number 3099067. UK VAT Group: GB 365 4626 36